Triethylene Glycol

Triethylene Glycol

SCHEMBL25366174

CCCC(CC)OC(CC)CCC.OCCOCCOCCO

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
THRB P10828 1/20 0.47
HTT P42858 1/20 0.47
MAPT P10636 1/20 0.47
TSHR P16473 3/20 0.46
MAPK1 P28482 2/20 0.42
ALDH1A1 P00352 2/20 0.41
PRKCA P17252 1/20 0.37
PRKCD Q05655 1/20 0.37
LMNA P02545 2/20 0.33
USP2 O75604 1/20 0.33
CYP3A4 P08684 1/20 0.33
CASP1 P29466 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SLCO1B3 Q9NPD5 1/20 0.33
SLCO1B1 Q9Y6L6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Di(Hydroxyethyl)Ether SCHEMBL4423733 0.98 TSHR (0.48) MEN1KMT2ATHRBHTTMAPT
SCHEMBL1665087 0.90 MEN1 (0.45) MEN1KMT2ATHRBHTTMAPT
SCHEMBL358536 0.90 MEN1 (0.45) MEN1KMT2ATHRBHTTMAPT
SCHEMBL31602068 0.90 MEN1 (0.45) MEN1KMT2ATHRBHTTMAPT
Di(Hydroxyethyl)Ether SCHEMBL4425237 0.89 TSHR (0.52) MEN1KMT2ATHRBHTTMAPT
Triethylene Glycol SCHEMBL25299251 0.88 TSHR (0.54) MEN1KMT2ATHRBHTTMAPT
Triethylene Glycol SCHEMBL25303237 0.87 MEN1 (0.55) MEN1KMT2ATHRBHTTMAPT
Triethylene Glycol SCHEMBL25303367 0.86 MEN1 (0.57) MEN1KMT2ATHRBHTTMAPT
Tetraethylene Glycol SCHEMBL2369345 0.86 MEN1 (0.57) MEN1KMT2ATHRBHTTMAPT
Di(Hydroxyethyl)Ether SCHEMBL4434394 0.86 TSHR (0.56) MEN1KMT2ATHRBHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12595387-B2 Ink composition for light-emitting device and light-emitting device manufactured by using the same SAMSUNG DISPLAY CO., LTD. (KR) 2026-04-07 US claimed
US-20230265306-A1 INK COMPOSITION FOR LIGHT-EMITTING DEVICE AND LIGHT-EMITTING DEVICE MANUFACTURED BY USING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2023-08-24 US claimed
US-12595387-B2 Ink composition for light-emitting device and light-emitting device manufactured by using the same SAMSUNG DISPLAY CO., LTD. (KR) 2026-04-07 US disclosed
CN-116640479-A Ink composition for light-emitting device, and electronic apparatus 三星显示有限公司 2023-08-25 CN disclosed
US-20230265306-A1 INK COMPOSITION FOR LIGHT-EMITTING DEVICE AND LIGHT-EMITTING DEVICE MANUFACTURED BY USING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2023-08-24 US disclosed
CN-101738863-B Photosensitive resin composition and display SUMITOMO CHEMICAL CO 2015-01-07 CN disclosed
CN-101738863-A Photosensitive resin composition and display SUMITOMO CHEMICAL CO 2010-06-16 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595387-B2 Ink composition for light-emitting device and light-emitting device manufactured by using the same CYBA, LASP1, MYH9 MEN1 4028/4885KMT2A 1506/4885THRB 4114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.